Celemics, Inc. Logo

Celemics, Inc.

Develops custom NGS panels and bioinformatics for research and clinical diagnostics.

331920 | KO

Overview

Corporate Details

ISIN(s):
KR7331920009
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산디지털1로 131, A동 19층 및 20층 2004호 외, 금천구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Celemics, Inc. is a biotechnology company specializing in Next-Generation Sequencing (NGS) solutions for research and clinical diagnostics. The company develops and manufactures a comprehensive portfolio of products, including hybridization-based NGS target enrichment panels, whole exome sequencing (WES) kits, library preparation kits, and bioinformatics analysis services. Utilizing proprietary technologies in probe design, molecular barcoding, and bioinformatics, Celemics provides both ready-to-use and fully customized panels tailored for various applications. Its key markets include oncology, liquid biopsy, biopharma, inherited disease analysis, pharmacogenomics, pathogen detection, and agrigenomics, offering end-to-end solutions from assay development to data analysis.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-05-19 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.8 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.2 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.1 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 430.2 KB
2025-03-19 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.5 MB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.8 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 158.7 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.3 KB
2025-03-04 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 159.1 KB
2025-02-19 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.9 KB
2024-12-17 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.6 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 1.1 MB

Automate Your Workflow. Get a real-time feed of all Celemics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celemics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celemics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KYONGBO PHARMACEUTICAL CO., LTD. Logo
Manufactures APIs and finished drugs, offering global CDMO services from development to production.
South Korea
214390
KYORIN Pharmaceutical Co., Ltd. Logo
Researches, develops, and sells a portfolio of ethical, generic, and OTC medicines.
Japan
4569
Kyowa Kirin Co.,Ltd. Logo
Develops antibody medicines for oncology, nephrology, immunology, and allergy.
Japan
4151
KyungdongPharm Logo
Develops and manufactures Rx/OTC drugs & APIs for cardiology and other chronic conditions.
South Korea
011040
KYUNG NAM PHARM.CO.,LTD. Logo
South Korean maker of OTC medicines, health foods, and cosmetics, known for its Lemona Vitamin C.
South Korea
053950
Kyverna Therapeutics, Inc. Logo
Developing CAR T-cell therapies for durable remission in autoimmune diseases.
United States of America
KYTX
Labiana S.A. Logo
Pharmaceutical CDMO for animal & human health with its own line of vaccines and generics.
Spain
LAB
Labocanna Spolka Akcyjna Logo
Cultivates and distributes medical marijuana and cannabinoid products for clinical and consumer use.
Poland
LCN
Labomar Logo
A CDMO developing custom supplements, medical devices & cosmetics for third-party clients.
Italy
LBM
Laboratorio Farmaceutico Erfo Logo
Full-service contract manufacturer of private label supplements and medical devices.
Italy
ERFO

Talk to a Data Expert

Have a question? We'll get back to you promptly.